Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits

Safety of high-dose micafungin for patients with hematological diseases

(2014) Sho Yamazaki et al.   LEUKEMIA & LYMPHOMA

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

(2013) M.N. Gamaletsou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection

(2012) J. L. Livermore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Flash pulmonary oedema during anidulafungin administration

(2011) C. B. Hindahl et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants

(2009) D K Benjamin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

(2009) P Brian Smith et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Cerebrospinal Fluid and Plasma (1->3)- -D-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis

(2008) R. Petraitiene et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates

(2007) William W. Hope et al.   JOURNAL OF INFECTIOUS DISEASES